EXJADE

Identification of Exjade

Please sign up for a free trial to see the description of this product.

Examples of the descriptions of OTHER drugs:

Lipitor 10 mg

Apo-Irbesartan 150 mg

Crestor 20 mg

Google image searchProduct monograph

Active ingredient

deferasirox, 250 MG

DIN: 02287439

Dosage form(s): TABLET FOR SUSPENSION

Route(s) of administration: ORAL

Schedule: Prescription

Company: NOVARTIS PHARMACEUTICALS CANADA INC

Date: 10-NOV-2006

ATC:

V03 — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD, )
V03A — ALL OTHER THERAPEUTIC PRODUCTS (ATC, ATC/DDD)
V03AC — Iron chelating agents (ATC, ATC/DDD)
V03AC03 — DEFERASIROX (ATC/DDD)

Reference brand drug: Exjade

Pharmaceutical standard: MFR

External Links for Exjade

Search on Google

Exjade side effects
Exjade dosage
deferasirox side effects
deferasirox dosage

Novartis Pharmaceuticals Canada Inc

Go to Novartis website to see drug product details. Sometimes you can find exjade photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.